Skip to main content
. 2009 May 8;2:49–62. doi: 10.2147/jaa.s3116

Figure 3.

Figure 3

Percentage of patients with reduction in dose of inhaled steroid at end of treatment in a study of omalizumab in a paediatric setting. Reproduced with permission from Milgrom H, Berger W, Nayak A, et al. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics. 2001;108:E36.44 Copyright © 2001 by the AAP.